Juvenile xanthogranuloma (JXG) isa benign, non-Langerhanscell histiocytic lesion that generally affects infants and children. These lesions characteristically appear as a solitary, yellow, cutaneous nodule of the head, neck, or trunk. Subcutaneous and extracutaneous forms can involve thegastrointestinal tract, kidney, lung, gonads, pericardium, central nervous system, temporal bone, larynx, and eye. We describe the clinical presentation, imaging, histochemicalfindings, and managementofasolitaryJXG of the tympanic membrane in a l Z-month-oid girl. The patient underwent surgical resection and was without disease several monthsfollowing surgery and reconstruction of the defect. To the bestof our knowledge, this is the first reported case of a JXG of the tympanic membrane.
Introduction
Juvenile xanthogranuloma OXG) is a benign, non-Langerhans cellhistiocytic lesion that ismost commonly found in or on the skin of the head, neck, or trunk. It was first described by Adamson in 1905 as congenital xanthomamultiplex. 1 In 1912,McDonagh renamed these lesions naevo-xantho-endotheiiomata,' In 1954, Helwig and Hackney called the condition xanthogranuloma based on its histologic appearance. ' To the best of our knowledge, no case of JXG of the tympanic membrane has been previously reported in the literature. We describe the clinical, imaging, surgical, and histochemical features of such a case, as well as our management of it. From 
Case report
A 17-rnonth-old girl was referred to us for evaluation of recurrent left-sided otitis media. Physical examination revealed that she had a bulging lesion in the posterosuperior quadrant of the left tympanic membrane. After further examination under local anesthesia, tympanostomy tube placement was carried out. During tube placement, the mass appeared as a yellow-white bulge that was suspicious for a cholesteatoma. On computed tomography (CT), the mass appeared as a 4 x 2 x 2-mm soft-tissue lesion at the level of the tympanic membrane along the malleus. No osseous erosion was noted. The patient underwent surgical resection of the lesion followed by a tympanoplasty to reconstruct the defect. Intraoperatively, the lesion was firm, homogeneous, pale yellow, and nonencapsulated (figure 1). It was isolated within the squamous and mucosal layers of the tympanic membrane. The mass was located lateral to the manubrium and did not extend beyond the squamous surface. Posteriorly, it could not be separated from the squamous and mucosal layers. Anteriorly, it was superficial to the fibrous layer and had irregular borders. The middle ear was normal.
Histologic examination of intraoperative frozen sections identified multinucleated giant cells and sheets of histiocytes (figure 2, A). No indications of malignancy were evident. Subsequent immunohistochemical staining was positive for CD68 (figure 2, B) and negative for CD1a, which helped clinch the diagnosis ofJXG. No skin lesions or cafe au lait spots were found on physical examination, and the patient's family history was negative for any cutaneous skin disorders. The tympanic membrane graft healed well postoperatively, and the patient exhibited no evidence of persistent disease during months of follow-up.
Discussion
The tympanic membrane is formed by the fusion of three embryologic layers: the endoderm, the mesoderm, and the ectoderm. The thin epidermal layer contains a dermal layer populated by dendritic cells, including . histiocytes. Primary lesions of the tympanic membrane are an unusual diagnosis; among them are intratympanic cholesteatomas, tympanosclerotic lesions, cholesterol granulomas, schwannomas, hemangiomas, squamous cell carcinomas, and meningiomas. Our case adds primary JXG to the list. JXG is a self-limited disorder that typically begins as one or more red cutaneous nodules that can become yellow, firm, and rubbery. They generally appear in infancy or childhood (mean age at onset: 22 mo), 35% of cases are present at birth, and only about 10% first manifest in adults.:" Most lesions spontaneously regress by the time a child reaches the age of 5 years. JXG occurs as a solitary lesion in 80% of cases, and it is systemic in 4% of cases." JXG is 10 times more common in whites than blacks, and there is a slight male preponderance (1.4:1). 6 These lesions most commonly affect the head, neck, and upper trunk, but they can appear on any skin surface. Lesions can also occur in the gastrointestinal tract, kidney, lung, gonads, pericardium, central nervous system, temporal bone, larynx, and eye. 8 -12 Conditions associated with JXG include neurofibromatosis type 1 (NF-l), Niemann-Pick disease, urticaria pigmentosa, and epilepsy."A thorough physical examination should be performed to identify hepatosplenomegaly, lymphadenopathy, cafe au lait spots, and other skin lesions. The combination of multiple JXGand NF-1 in a patient is associated with juvenile myelomonocytic leukemia."
The etiology and pathophysiology oOXG are not fully understood. There is debate as to whether a reactive or neoplastic process occurs and whether it represents a granulomatous reaction of histiocytes to a physical or infectious stimulus." The cells of origin in JXG are likely dermal dendritic cells." The precursor cells are the CD34+ progenitor cells, which can differentiate into either CD14+/ CD1a-histiocytes OXG) or CD14-/CDla+ Langerhans cells(Langerhans cell histiocytosis), depending on cytokine signaling." Thus, JXGand Langerhans cell histiocytosis are both categorized as dendritic cell-related disorders, as 366 • www.entjournal.com .. .
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and desm in. The absence of nuclear grooves and negative staining for S-100 protein differentiates JXG from Langerhans cell disea se.
Differen t forms of JXG have been described based on clinical and hist ologic features. Subcutaneous lesions, which have bee n reported to represent about 5% of cases, are typically solitary. deep-seated, and often congenital or perinatal lesions 10 to 20 mm in diameter." Deep lesion s may be more cellular and monotonous and may contain fewer Touton cells.' Other forms include micronodular, macronodu lar.g iant ,clustered, lichen oid, and plaque-like lesions."
Treatment options for JXGare expectant observation, sur gical excision, radiotherapy, corticosteroid therapy and , in rare cases, che motherapy. JXG lesions often regress spontaneously without any sequelae except for atrophic scarring or altered pigmentation.Il. Surgica l resection is necessary for symptomatic cases or as an option for diagnostic and cosmetic con cerns. Systemic and intralesional injections of corticosteroids have been reported to promote regression ofjXG lesions." :" Chemotherapy is indicated in rare cases of severe systemic JXGj 15cases ofsystemic treatment with corticosteroids and vinca alkaloids, methotrexate, or etop oside have been reported .IS In concl usion, JXG is a rare, benign. cutaneo us lesion ofthe non -Langerhans cellgroup ofhistiocytic disorders. Because it often affects the head and neck, otolaryngologists should be aware of th is ent ity in order to make a correct diagnosis, to formu late a treatment plan, and to understand the po ssible complications and associated medical conditions. To the best of our knowledge, our case represents the first published report of a JXG of the tympanic membrane .
